Neuehealth Stock Performance
| NEUE Stock | 6.84 0.03 0.44% |
NeueHealth has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NeueHealth's returns are expected to increase less than the market. However, during the bear market, the loss of holding NeueHealth is expected to be smaller as well. NeueHealth right now secures a risk of 0.96%. Please verify NeueHealth skewness, and the relationship between the potential upside and rate of daily change , to decide if NeueHealth will be following its current price movements.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NeueHealth are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, NeueHealth is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (0.58) | Five Day Return (1.87) | Year To Date Return (7.09) | Ten Year Return (99.49) | All Time Return (99.49) |
Last Split Factor 1:80 | Last Split Date 2023-05-22 |
1 | TUMI PRSENTIERT NEUE 19 DEGREE LITE KOLLEKTION MIT GLOBALEN MARKENBOTSCHAFTER LANDO NORRIS | 05/01/2025 |
2 | Disposition of tradable shares by Jay Matushak of NeueHealth at 5.18 subject to Rule 16b-3 | 05/02/2025 |
3 | NeueHealth Reports First Quarter 2025 Results | 05/08/2025 |
4 | Q1 2025 NeueHealth Inc Earnings Call Transcript | 05/09/2025 |
5 | Disposition of 472 shares by Jay Matushak of NeueHealth at 6.76 subject to Rule 16b-3 | 05/12/2025 |
6 | Disposition of 10500 shares by Slavitt Andrew M of NeueHealth subject to Rule 16b-3 | 05/13/2025 |
7 | Disposition of 10500 shares by Kadre Manuel of NeueHealth subject to Rule 16b-3 | 05/15/2025 |
8 | Acquisition by Tomas Orozco of 71 shares of NeueHealth subject to Rule 16b-3 | 06/20/2025 |
9 | Financial Contrast Auna vs. NeueHealth | 06/23/2025 |
10 | NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 | 07/17/2025 |
| Begin Period Cash Flow | 375.3 M | |
| Total Cashflows From Investing Activities | 186.9 M | |
| Free Cash Flow | -125.5 M |
NeueHealth | Build AI portfolio with NeueHealth Stock |
NeueHealth Relative Risk vs. Return Landscape
If you would invest 665.00 in NeueHealth on April 22, 2025 and sell it today you would earn a total of 18.50 from holding NeueHealth or generate 2.78% return on investment over 90 days. NeueHealth is currently generating 0.0481% in daily expected returns and assumes 0.9615% risk (volatility on return distribution) over the 90 days horizon. In different words, 8% of stocks are less volatile than NeueHealth, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NeueHealth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeueHealth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NeueHealth, and traders can use it to determine the average amount a NeueHealth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.05
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NEUE |
Estimated Market Risk
| 0.96 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.05 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average NeueHealth is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeueHealth by adding it to a well-diversified portfolio.
NeueHealth Fundamentals Growth
NeueHealth Stock prices reflect investors' perceptions of the future prospects and financial health of NeueHealth, and NeueHealth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NeueHealth Stock performance.
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.0413 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 1.04 B | ||||
| Shares Outstanding | 8.93 M | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 936.66 M | ||||
| Gross Profit | 201.19 M | ||||
| EBITDA | (80.76 M) | ||||
| Net Income | (99.72 M) | ||||
| Total Debt | 204.61 M | ||||
| Book Value Per Share | (153.00) X | ||||
| Cash Flow From Operations | (123.22 M) | ||||
| Earnings Per Share | (22.42) X | ||||
| Market Capitalization | 60.8 M | ||||
| Total Asset | 544.38 M | ||||
| Retained Earnings | (4.44 B) | ||||
| Working Capital | (275.58 M) | ||||
About NeueHealth Performance
By analyzing NeueHealth's fundamental ratios, stakeholders can gain valuable insights into NeueHealth's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NeueHealth has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NeueHealth has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.6 K | 818 | |
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | 0.62 | 0.42 | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | 0.31 | 0.33 |
Things to note about NeueHealth performance evaluation
Checking the ongoing alerts about NeueHealth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NeueHealth help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NeueHealth has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 936.66 M. Net Loss for the year was (99.72 M) with profit before overhead, payroll, taxes, and interest of 201.19 M. | |
| NeueHealth generates negative cash flow from operations | |
| NeueHealth has a poor financial position based on the latest SEC disclosures | |
| About 59.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 |
- Analyzing NeueHealth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NeueHealth's stock is overvalued or undervalued compared to its peers.
- Examining NeueHealth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NeueHealth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NeueHealth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NeueHealth's stock. These opinions can provide insight into NeueHealth's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |